85 related articles for article (PubMed ID: 25668179)
21. A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening.
Davies P; Arbyn M; Dillner J; Kitchener HC; Meijer CJ; Ronco G; Hakama M
Int J Cancer; 2006 Feb; 118(4):791-6. PubMed ID: 16287075
[TBL] [Abstract][Full Text] [Related]
22. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
23. HPV detection methods and genotyping techniques in screening for cervical cancer.
Eide ML; Debaque H
Ann Pathol; 2012 Dec; 32(6):e15-23, 401-9. PubMed ID: 23244480
[TBL] [Abstract][Full Text] [Related]
24. cobas 4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens.
Isidean SD; Coutlée F; Franco EL
Expert Rev Mol Diagn; 2014 Jan; 14(1):5-16. PubMed ID: 24308341
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States.
Roland KB; Soman A; Benard VB; Saraiya M
Am J Obstet Gynecol; 2011 Nov; 205(5):447.e1-8. PubMed ID: 21840492
[TBL] [Abstract][Full Text] [Related]
26. Cervical screening: primary human papillomavirus testing.
Cruickshank ME; Cubie HA
BJOG; 2012 May; 119(6):650-2. PubMed ID: 22489759
[No Abstract] [Full Text] [Related]
27. FDA panel conditionally approves DNA pap test without ACOG support.
Ostrzenski A
J Natl Med Assoc; 2002 Jun; 94(6):418. PubMed ID: 12078919
[No Abstract] [Full Text] [Related]
28. HPV Testing in Resource-Limited Settings: How Can We Reach the Next Level of Cervical Cancer Screening in Latin America and the Caribbean?
Randall TC; Salicrup LA; Luciani S; Trimble EL
Oncologist; 2015 Oct; 20(10):1101-4. PubMed ID: 26330459
[TBL] [Abstract][Full Text] [Related]
29. [HPV screening for cervical cancer--the calculation of the Swedish National Board of Health and Welfare is too pessimistic].
Wilander E
Lakartidningen; 2015 Dec; 112():. PubMed ID: 26625106
[No Abstract] [Full Text] [Related]
30. Statement on human papillomavirus DNA test utilization.
Solomon D; Papillo JL; Davey DD;
Arch Pathol Lab Med; 2009 Aug; 133(8):1276-7. PubMed ID: 19653725
[No Abstract] [Full Text] [Related]
31. Screening for Cervical Cancer: New Tools and New Opportunities.
Learman LA; Garcia FAR
JAMA; 2018 Aug; 320(7):647-649. PubMed ID: 30140859
[No Abstract] [Full Text] [Related]
32. [Safe implementation of HPV testing in the Norwegian Cervical Cancer Screening Programme].
Tropé A; Engesæter B; Nygård M; Andreassen T; Lönnberg S; Ursin G
Tidsskr Nor Laegeforen; 2017 Sep; 137(17):. PubMed ID: 28925234
[No Abstract] [Full Text] [Related]
33. Statement on HPV DNA test utilization.
Solomon D; Papillo JL; Davey DD
Diagn Cytopathol; 2009 Jul; 37(7):542-3. PubMed ID: 19459173
[No Abstract] [Full Text] [Related]
34. New screening tests for bowel and cervical cancer are to be piloted in NHS.
Hawkes N
BMJ; 2012 Dec; 345():e8455. PubMed ID: 23236053
[No Abstract] [Full Text] [Related]
35. Changes on the horizon for cervical cancer screening.
Isidean SD; Shinder GA
Prev Med; 2017 May; 98():1-2. PubMed ID: 28034732
[No Abstract] [Full Text] [Related]
36. Better HPV vaccination and cervical cancer screening needed.
O'Rourke K
Cancer; 2022 Apr; 128(8):1559. PubMed ID: 35319090
[No Abstract] [Full Text] [Related]
37. Implementation in action: Collaborating on the transition to primary HPV screening for cervical cancer in the United States.
Downs LS; Nayar R; Gerndt J; Saslow D;
CA Cancer J Clin; 2023; 73(5):458-460. PubMed ID: 37347977
[No Abstract] [Full Text] [Related]
38. The changing face of cervical cancer screening in the United States.
Huh WK
J Natl Compr Canc Netw; 2010 Dec; 8(12):1329-30. PubMed ID: 21147899
[No Abstract] [Full Text] [Related]
39. 'Missing Adenocarcinomas': Are They a Real Problem in Cervical Cancer Screening in Brazil?
Vale DB; Bragança JF; Zeferino LC
Rev Bras Ginecol Obstet; 2019 Oct; 41(10):579-580. PubMed ID: 31658486
[No Abstract] [Full Text] [Related]
40. Cervical cancer caused by human papillomavirus: Highly preventable yet highly under-diagnosed.
Memon MM; Amin E
J Pak Med Assoc; 2018 May; 68(5):831. PubMed ID: 29885197
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
